Form 4: American Oncology Network Director Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Stephen Divers, Chief Medical Officer and Director at American Oncology Network, sold shares to cover tax obligations related to vesting stock.

Summary

  • On March 20, 2024, Stephen Divers, Chief Medical Officer and Director of American Oncology Network, Inc. (AONC), engaged in a transaction involving Class A Common Stock.
  • Divers sold 8,554 shares of Class A Common Stock at a price of $5.7 per share to cover tax obligations related to the vesting of 29,750 shares.
  • Following the transaction, Divers directly owns 57,470 shares of Class A Common Stock.
  • Divers also indirectly owns 37,499 shares through Divers Investments, LLC and 63,857 shares through the Stephen G. Divers, M.D., Trustee FBO Fred Divers Family Trust.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the executive's confidence in the company.

Stakeholder Impact

  • The sale of shares could have a minor, temporary impact on the stock price.

Key Dates

DateDescription
03/20/2024Date of the transaction (sale of shares).
03/22/2024Date of signature on the Form 4 filing.

Keywords

Form 4, AONC, American Oncology Network, Stephen Divers, Share Sale, Tax Obligations, Class A Common Stock, Director, Chief Medical Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.